BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/24/2020 12:41:21 PM | Browse: 551 | Download: 1269
Publication Name World Journal of Hepatology
Manuscript ID 58287
Country United States
Received
2020-07-16 22:21
Peer-Review Started
2020-07-16 22:22
To Make the First Decision
Return for Revision
2020-09-14 20:58
Revised
2020-09-16 17:24
Second Decision
2020-09-30 08:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-10-05 17:50
Articles in Press
2020-10-05 17:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-11-16 00:43
Publish the Manuscript Online
2020-11-24 12:41
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells
Manuscript Source Invited Manuscript
All Author List Moses New-Aaron, Murali Ganesan, Raghubendra Singh Dagur, Kusum K Kharbanda, Larisa Y Poluektova and Natalia A Osna
ORCID
Author(s) ORCID Number
Moses New-Aaron http://orcid.org/0000-0001-5681-1185
Murali Ganesan http://orcid.org/0000-0002-2981-568X
Raghubendra Singh Dagur http://orcid.org/0000-0001-9337-149X
Kusum K Kharbanda http://orcid.org/0000-0001-7759-8889
Larisa Y Poluektova http://orcid.org/0000-0001-7339-8732
Natalia A Osna http://orcid.org/0000-0001-7498-0556
Funding Agency and Grant Number
Funding Agency Grant Number
National Institutes of Health R01AA027189-01A1
Corresponding Author Natalia A Osna, MD, PhD, Associate Professor, Research Service, Veterans Affairs Nebraska-Western Iowa Health Care System, 4101 Woolworth Ave, Omaha, NE 68105, United States. nosna@unmc.edu
Key Words Human immunodeficiency virus; Liver; Obeticholic acid; Alcohol; Hepatocytes; Fibrosis
Core Tip We investigated the ability of obeticholic acid (OCA) to reverse pro-fibrotic effects of human immunodeficiency virus (HIV) and ethanol metabolism in liver cells. Based on our previous studies, hepatocyte apoptosis occurs under combined exposure of cells to HIV and ethanol metabolites. The subsequent engulfment of HIV-containing apoptotic hepatocytes by hepatic stellate cells induced pro-fibrotic activation in these cells, thereby promoting fibrosis development. Here, we demonstrated that OCA attenuates hepatocyte apoptosis by preventing accumulation of HIV components in liver cells exposed to HIV and acetaldehyde-generating system (AGS) mimicking natural ethanol metabolism in primary hepatocytes. These beneficial effects of OCA are attributed to suppression of oxidative stress leading to restoration of HIV-AGS-impaired proteasomal and lysosomal functions in liver cells. OCA also reduces activation of inflammasome in hepatic stellate cells and their pro-fibrotic activation. Thus, anti-fibrotic properties of OCA can be used for combined treatment of HIV-infected alcohol abusers with a high risk of liver fibrosis development.
Publish Date 2020-11-24 12:41
Citation New-Aaron M, Ganesan M, Dagur RS, Kharbanda KK, Poluektova LY, Osna NA. Obeticholic Acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells. World J Hepatol 2020; 12(11): 965-975
URL https://www.wjgnet.com/1948-5182/full/v12/i11/965.htm
DOI https://dx.doi.org/10.4254/wjh.v12.i11.965
Full Article (PDF) WJH-12-965.pdf
Full Article (Word) WJH-12-965.docx
The ARRIVE Guidelines 58287-The-ARRIVE-Guidelines-revision.pdf
Manuscript File 58287_Auto_Edited.docx
Answering Reviewers 58287-Answering reviewers.pdf
Audio Core Tip 58287-Audio core tip.m4a
Biostatistics Review Certificate 58287-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 58287-Conflict-of-interest statement.pdf
Copyright License Agreement 58287-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 58287-Grant application form(s).pdf
Institutional Review Board Approval Form or Document 58287-Institutional review board statement.pdf
Peer-review Report 58287-Peer-review(s).pdf
Scientific Misconduct Check 58287-Bing-Yan JP-1.png
Scientific Misconduct Check 58287-Scientific misconduct check.pdf
Scientific Editor Work List 58287-Scientific editor work list.pdf